Hippocampal Neurochemical Profile and Glucose Transport Kinetics in Patients With Type 1 Diabetes

被引:6
|
作者
Bednarik, Petr [1 ,2 ,3 ,4 ]
Henry, Pierre-Gilles [1 ]
Khowaja, Amir [2 ]
Rubin, Nathan [5 ]
Kumar, Anjali [2 ]
Deelchand, Dinesh [1 ]
Eberly, Lynn E. [5 ]
Seaquist, Elizabeth [2 ]
Oz, Gulin [1 ]
Moheet, Amir [2 ]
机构
[1] Univ Minnesota, Ctr Magnet Resonance Res, Dept Radiol, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Med, Div Diabet Endocrinol & Metab, MMC 101,420 Delaware St SE, Minneapolis, MN 55455 USA
[3] Med Univ Vienna, High Field MR Ctr, Dept Biomed Imaging & Image Guided Therapy, A-1090 Vienna, Austria
[4] Univ Ostrava, Fac Med, Dept Imaging Methods, Ostrava 70300, Czech Republic
[5] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA
来源
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2020年 / 105卷 / 02期
基金
美国国家卫生研究院;
关键词
MAGNETIC-RESONANCE SPECTROSCOPY; CENTRAL-NERVOUS-SYSTEM; COGNITIVE FUNCTION; RAT-BRAIN; HYPOGLYCEMIA AWARENESS; RECURRENT HYPOGLYCEMIA; CHRONIC HYPERGLYCEMIA; METABOLITE CHANGES; AUTONOMIC FAILURE; SHORT-ECHO;
D O I
10.1210/clinem/dgz062
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Longstanding type 1 diabetes (T1D) may lead to alterations in hippocampal neurochemical profile. Upregulation of hippocampal glucose transport as a result of recurrent exposure to hypoglycemia may preserve cognitive function during future hypoglycemia in subjects with T1D and impaired awareness of hypoglycemia (IAH). The effect of T1D on hippocampal neurochemical profile and glucose transport is unknown. Objective: To test the hypothesis that hippocampal neurochemical composition is altered in T1D and glucose transport is upregulated in T1D with IAH. Design and participants: Hippocampal neurochemical profile was measured with single-voxel magnetic resonance spectroscopy at 3T during euglycemia in 18 healthy controls (HC), 10 T1D with IAH, and 12 T1D with normal awareness to hypoglycemia (NAH). Additionally, 12 HC, 8 T1D-IAH, and 6 T1D-NAH were scanned during hyperglycemia to assess hippocampal glucose transport with metabolic modeling. Setting: University medical center. Main Outcome Measures: Concentrations of hippocampal neurochemicals measured during euglycemia and ratios of maximal transport rate to cerebral metabolic rate of glucose (T-max/CMRGlc), derived from magnetic resonance spectroscopy-measured hippocampal glucose as a function of plasma glucose. Results: Comparison of hippocampal neurochemical profile revealed no group differences (HC, T1D, T1D-IAH, and T1D-NAH). The ratio T-max/CMRGlc was not significantly different between the groups, T1D-IAH (1.58 +/- 0.09) and HC (1.65 +/- 0.07, P = 0.54), between T1D-NAH (1.50 +/- 0.09) and HC (P = 0.19), and between T1D-IAH and T1D-NAH (P = 0.53). Conclusions. Subjects with T1D with sufficient exposure to recurrent hypoglycemia to create IAH did not have alteration of T-max/CMRglc or neurochemical profile compared with participants with T1D-NAH or HC.
引用
收藏
页码:479 / 491
页数:13
相关论文
共 50 条
  • [31] Glucocorticoid Receptor Blockade Normalizes Hippocampal Alterations and Cognitive Impairment in Streptozotocin-Induced Type 1 Diabetes Mice
    Revsin, Yanina
    Rekers, Niels V.
    Louwe, Mieke C.
    Saravia, Flavia E.
    De Nicola, Alejandro F.
    de Kloet, E. Ron
    Oitzl, Melly S.
    NEUROPSYCHOPHARMACOLOGY, 2009, 34 (03) : 747 - 758
  • [32] A Prognostic Model of the Development of Cognitive Impairments in Patients with Type 1 Diabetes Mellitus
    Samoilova Y.G.
    Rotkank M.A.
    Kudlay D.A.
    Zhukova N.G.
    Matveeva M.V.
    Tolmachev I.V.
    Neuroscience and Behavioral Physiology, 2020, 50 (9) : 1136 - 1139
  • [33] Recognition, Prevention, and Proactive Management of Hypoglycemia in Patients with Type 1 Diabetes Mellitus
    Unger, Jeff
    Parkin, Christopher
    POSTGRADUATE MEDICINE, 2011, 123 (04) : 71 - 80
  • [34] Relationships between Glucose Variability and Conventional Measures of Glycemic Control in Continuously Monitored Patients with Type 2 Diabetes
    Kohnert, K. -D.
    Vogt, L.
    Augstein, P.
    Heinke, P.
    Zander, E.
    Peterson, K.
    Freysel, E. -J.
    Salzsieder, E.
    HORMONE AND METABOLIC RESEARCH, 2009, 41 (02) : 137 - 141
  • [35] Patterns of Adherence to Oral Hypoglycemic Agents and Glucose Control among Primary Care Patients with Type 2 Diabetes
    McClintock, Heather F. de Vries
    Morales, Knashawn H.
    Small, Dylan S.
    Bogner, Hillary R.
    BEHAVIORAL MEDICINE, 2016, 42 (02) : 63 - 71
  • [36] Analysis of Hemodialysis-Associated Hypoglycemia in Patients with Type 2 Diabetes Using a Continuous Glucose Monitoring System
    Jung, Hye Seung
    Kim, Hong Il
    Kim, Min Joo
    Yoon, Ji Won
    Ahn, Hwa Young
    Cho, Young Min
    Oh, Kook-Hwan
    Joo, Kwon Wook
    Lee, Jung Geon
    Kim, Seong Yeon
    Park, Kyong Soo
    DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (10) : 801 - 807
  • [37] Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes
    Colette, C.
    Monnier, L.
    HORMONE AND METABOLIC RESEARCH, 2007, 39 (09) : 683 - 686
  • [38] HYPOGLYCEMIA UNAWARENESS IN TYPE-1 DIABETES - A LOWER PLASMA-GLUCOSE IS REQUIRED TO STIMULATE SYMPATHOADRENAL ACTIVATION
    HEPBURN, DA
    PATRICK, AW
    BRASH, HM
    THOMSON, I
    FRIER, BM
    DIABETIC MEDICINE, 1991, 8 (10) : 934 - 945
  • [39] Measurement of cerebral oxidative glucose consumption in patients with type 1 diabetes mellitus and hypoglycemia unawareness using 13C nuclear magnetic resonance spectroscopy
    Henry, Pierre-Gilles
    Criego, Amy B.
    Kumar, Anjali
    Seaquist, Elizabeth R.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (01): : 100 - 106
  • [40] Evidence for abnormal glucose uptake or metabolism in thalamus during acute hyperglycaemia in type 1 diabetes—a 1H MRS study
    Outi Heikkilä
    Nina Lundbom
    Marjut Timonen
    Per-Henrik Groop
    Sami Heikkinen
    Sari Mäkimattila
    Metabolic Brain Disease, 2010, 25 : 227 - 234